DEI/Health Equity

1

Date of Presentation

5-2-2024 12:00 AM

College

Rowan-Virtua School of Osteopathic Medicine

Poster Abstract

As the prevalence of chronic pain rises, the number of patients prescribed opioids is increasing. Consequently, the rate of opioid overdose has increased, becoming a public health concern.For these reasons, the Center for Disease Control and Prevention recommended co-prescribing naloxone, a medicine that reverses the effects of opioid overdose.While this medication can be lifesaving, it is not accessible or available to everyone in need of it. A systematic review of existing literature pertaining to the barriers in patients receiving naloxone was conducted to evaluate the major obstacles in patients receiving a naloxone co-prescription. The results show that the major deterrents include financial cost, geographic location, education, and stigma. Based on these findings, it is recommended that more trainings, information, and awareness should be distributed about naloxone to increase familiarity and decrease stigma in many communities.

Keywords

Chronic Pain, Pain Management, Naloxone, Opioid Use, Opioid Analgesics, Social Stigma, Health Services Accessibility

Disciplines

Anesthesia and Analgesia | Health and Medical Administration | Health Services Administration | Medicine and Health Sciences | Patient Safety | Pharmaceutical Preparations | Public Health Education and Promotion | Substance Abuse and Addiction | Therapeutics

Document Type

Poster

DOI

10.31986/issn.2689-0690_rdw.stratford_research_day.152_2024

Share

COinS
 
May 2nd, 12:00 AM

Barriers in Obtaining a Naloxone Co-prescription for Patients Who Are Prescribed Opioids for Pain Management

As the prevalence of chronic pain rises, the number of patients prescribed opioids is increasing. Consequently, the rate of opioid overdose has increased, becoming a public health concern.For these reasons, the Center for Disease Control and Prevention recommended co-prescribing naloxone, a medicine that reverses the effects of opioid overdose.While this medication can be lifesaving, it is not accessible or available to everyone in need of it. A systematic review of existing literature pertaining to the barriers in patients receiving naloxone was conducted to evaluate the major obstacles in patients receiving a naloxone co-prescription. The results show that the major deterrents include financial cost, geographic location, education, and stigma. Based on these findings, it is recommended that more trainings, information, and awareness should be distributed about naloxone to increase familiarity and decrease stigma in many communities.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.